Review the discount offers and pharmacy prices below. This is not a complete list of side effects and others may occur. • Yupelri should be used with caution in patients with narrow-angle glaucoma. Adverse Effects (1) Most common, ≥ 2% Yupelri (n=395) % Placebo (n=418) % Cough 4 4 Nasopharyngitis 4 2How to say (YUPELRI) Listen and learn the pronunciation of Yupelri in English. Yupelri. • It is an anticholinergic medicine which helps the. See GoodRx coupons. 0. 50% of reviewers reported a positive effect, while 50% reported a negative effect. Open Pouch: Open the foil pouch by tearing along the seam of the pouch. Following oral inhalation, peak plasma concentrations of revefenacin and its active metabolite reached within 14–41 minutes after initiation of nebulization. 50% of reviewers reported a positive effect, while 50% reported a negative effect. This Savings Card may be used to reduce the amount of your out-of-pocket costs for YUPELRI up to a maximum of $550 per 30-day prescription while. YUPELRI. com. The adverse reactions reported in theYupelri has an average rating of 6. S. For professionals: AHFS DI Monograph. Consumers using the ScriptSave WellRx savings program can expect average savings of 65% and, in some cases, it can be 80% or more* on brand and generic prescription. No insurance needed, no membership fees!$48. Research and Development (R&D) Expenses: R&D expenses for the fourth quarter of 2020 were $65. Yupelri is used to treat the following conditions: COPD. While Viatris records the total net sales of YUPELRI within its financial statements, Theravance Biopharma's implied 35% share of net sales of YUPELRI for the second quarter of 2022 was $17. As with other inhaled medicines, YUPELRI can produce paradoxical bronchospasm that may be life-threatening. Mobile App; Discount Card; Blog; Help; Yupelri. Learn More. The new HCPCS code is J7677 (REVEFENACIN INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, 1 MICROGRAM). Get Rx Coupon; Retailer Name. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced enrollment of the first patient in a Phase 4 study of YUPELRI ® (revefenacin) inhalation solution, the first and only once-daily, nebulized bronchodilator approved in the US for the maintenance treatment. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced enrollment of the first patient in a Phase 4 study of YUPELRI ® (revefenacin) inhalation solution, the first and only once-daily, nebulized bronchodilator approved in the US for the maintenance treatment of patients with chronic obstructive pulmonary. 27 by using the WebMDRx coupon, a savings. No other purchase is necessary. 61 por vial-neb for 1 vial-nebs. Issued: July 9, 2019. View Coupon: Viatris Patient Assistance Program (Group One Medicines) This program provides brand name medications at no or low cost: Provided by: Viatris Inc. are pharmaceutical companies that developed the medication. As a guide, Yupelri inhalation solution (175 mcg/3 mL) will typically cost around $1,200 for 90 milliliters. Each vial contains 175 mcg of revefenacin in 3 mL of an isotonic, sterile aqueous solution containing citric acid, sodium chloride, sodium citrate, and water for injection at pH 5. YUPELRI ® (revefenacin) inhalation solution, the first and only once-daily, nebulized bronchodilator approved in the US for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), achieved $47. The drug is manufactured by Mylan Specialty L. Medications may be discounted as much as 80% from the retail price. Spiriva’s most common side effects are upper respiratory infection, sinusitis, chest pain, dry mouth, constipation, and urinary tract infection. The thumbs up came a few days ahead of the inhaled therapy's Nov. It’s only available as a brand medication, so it can be very expensive. The non-shared YUPELRI costs incurred by us are recorded within operating. This website stores data such as cookies to enable essential site functionality, as well as marketing, personalization, and analytics. (NASDAQ: TBPH) today announced positive results from the YUPELRI® (revefenacin) Phase III placebo. The document provides the details of the clinical, pharmacological, and statistical evaluations of the drug by the FDA. Squeeze all of the medicine from the vial into the nebulizer cup. Common side effects may include: headache; back pain; or. 41. QTY 90 • 175MCG/3ML • VIAL-NEB • Near 77381. The agreement could make Yupelri available in the future to the nearly 100 million COPD patients living in China, where 43% have moderate to severe forms of the disease, and COPD is in one of the three top causes of death. Teva has been granted a royalty-free, non-exclusive license. People who are Black or who have had angioedema and take ENTRESTO. 3 million 1; Progress made towards the achievement of non-GAAP. Yupelri can cause serious side effects, including sudden breathing problems, new or worsened eye problems (acute narrow-angle glaucoma), or urinary retention. 1 Mechanism of Action - Revefenacin is a long-acting muscarinic antagonist, which is often referred to as an anticholinergic. Our Concierge. COPD is a long-term (chronic) lung disease that includes chronic bronchitis, emphysema, or both. 0 out of 10 from a total of 3 ratings on Drugs. Revefenacin Save on your Yupelri prescription. YUPELRI ® (revefenacin) inhalation solution, the first and only once-daily, nebulized bronchodilator approved in the US for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), continued to increase market share and achieved year-over-year net sales growth of 13%; its share of the long-acting nebulized COPD. Each dose takes about 8 minutes, but it only needs to be taken once a day. Get drug details on and other drugs at CVS, Walgreens, and other nearby pharmacies. Yupelri is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD) in adults. Medicare is a federal health insurance program that provides comprehensive healthcare coverage for those 65 or older. 61% to 69% of patients believed that. Free coupon for discounts on your prescription. Based on successful discussions with the FDA, we will conduct one additional study in MSA patients which is planned to start in Q1. Learn more. Drug Monograph. Common cold. 99. cold symptoms such as runny nose, sneezing, cough, sore throat. Want an exact price for your co-pay?YUPELRI at the recommended dose of 175 mcg once daily. ordered Yupleri and I have just taken it, The results of the trials seem. (NASDAQ: TBPH) today announced positive results from. 12 CLINICAL PHARMACOLOGY. When you get a yupelri coupon or discount card for free from RxLess, you'll pay the lowest possible price for your medication. But within a month I was much worse. 12. Yupelri (revefenacin) is used to treat chronic obstructive pulmonary disease (COPD). See images of for shape, color, size and other drugs at CVS, Walgreens, and other nearby pharmacies. $458. gov Identifier: NCT02512510) , the least square mean change in trough FEV 1 was 102mL and -45mL in the Yupelri and placebo groups, respectively (treatment difference 147. Tretinoin 45g of 0. 57 reviews. Yupelri has an average rating of 6. With this Savings Card, you may pay as little as $0 for each monthly fill of YUPELRI, while this program remains in effect. Yupelri Solution (revefenacin) NC NC NC NC PA Incruse Ellipta (umeclidinium) - DPI PA (Tier 2;3;4 once approved) inhaler/month Tier 2;3 NC Tier 3 PA > 1 Long-acting muscarinic antagonists (LAMA)/Long-acting beta agonists (LABA)For processing questions, call Argus Health Systems at 1-866-921-7286 or visit drugdiscountcardinfo. 100% of reviewers reported a positive effect, while 0% reported. 15, you can save money by using a GoodRx coupon instead. 0%. Spiriva has an average rating of 5. Program Website : Program Applications and Forms YUPELRI is supplied as 3 mL of revefenacin solution packaged in a unit-dose low-density polyethylene vial overwrapped in a foil pouch. Total scripts were up 7. Arformoterol has an average rating of 9. The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for YUPELRI and is publishing this notice of that determination as required by law. Research and Development (R&D) Expenses: R&D expenses for the second quarter of 2021 were $51. The only recommended dosage of Yupelri is one 175 mcg vial, taken once per day. You are responsible for paying the remaining 20% of the cost. Open Pouch: Open the foil pouch by tearing along the seam of the pouch. Medicare Part B (also called Fee-for-Service, Original Medicare, or Red, White, and Blue) covers 80% of the cost of COPD treatments like YUPELRI. Vanderbilt University Medical Center 1211 Medical Center Drive, Nashville, TN 37232 (615) 322-5000Study with Quizlet and memorize flashcards containing terms like YUPELRI (revefenacin) inhalation solution is indicated for the _____ treatment of patients with chronic COPD, The recommended does of YUPELRI is _____ by standard jet nebulizer using a mouthpiece, Dosage adjustment is required for geriatric patients, or patients with renal. To determine if you may be eligible, select your medicine from the menu below and follow the instructions shown on the application. Yupelri use should be discontinued if paradoxical bronchospasm occurs. com. The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for YUPELRI and is publishing this notice of that determination as required by law. COPD, Maintenance; COPDas low as. Get drug details on Yupelri and other Asthma and Respiratory drugs at CVS, Walgreens, and other nearby pharmacies. Offers of brand name medicine (over-the-counter and prescription) and medical supplies. 50% of reviewers reported a positive experience, while 50% reported a negative experience. Offer subject to a monthly cap of wholesale acquisition cost plus usual and customary pharmacy charges and a separate annual cap of $16,000. Cost With Our Coupon. YUPELRI is a prescription medicine used to treat chronic obstructive pulmonary disease (COPD), a long-term (chronic) lung disease that includes chronic bronchitis, emphysema, or both. 6 million. Pharmacies listed above readily accept RxSaver Coupons. , is a long-acting muscarinic antagonist (LAMA), which is the first and only once-daily, nebulized bronchodilator approved for the treatment of. Prescription. PITTSBURGH and DUBLIN, Nov. Learn about the different types of. Click on a tab below…. runny nose. For Breztri Aerosphere, Lonhala Magnair, Seebri Neohaler, Tudorza, and Yupelri (must meet all): 1. (TBPH) announced positive results from the YUPELRI Phase III placebo-controlled. 65% of reviewers reported a positive effect, while 19% reported a negative effect. 2 million, up 12% DUBLIN, Jan. 10, 2022 /PRNewswire/ -- Theravance Biopharma, Inc. 15, 2023 /PRNewswire/ -- Theravance Biopharma, Inc. com. No insurance needed, no membership fees! eye pain or redness, seeing halos around lights, painful or difficult urination, and. In this trial, 335 patients were treated with YUPELRI 175 mcg once daily. Look up prices and save on Yupelri and other drugs at CVS, Walgreens, and other nearby pharmacies. Step 1. 69 Cost. Revefenacin (Yupelri) is an anti-muscarinic agent. If your Medicare co-pay is higher than $504. Patent and Trademark Office (USPTO), Department of Commerce, for. On average, the retail price of Yupelri is $1,632. Symbicort has an average rating of 6. Long-acting beta 2-adrenergic agonists (LABA), such as salmeterol, one of the active ingredients in ADVAIR DISKUS®, increase the risk of asthma-related death. . 12. While Theravance earns 35% of the profits, Mylan receives the remaining 65%. Find medical information for Yupelri on epocrates online, including its dosing, contraindications, drug interactions, and pill pictures. Print,. Using the PARI LC ® Sprint Reusable Nebulizer. The trials assessed the therapeutic activity of two doses (88 mcg and 175 mcg) of Yupelri inhalation solution, administered once daily. Today I have taken my first dose of Yupelri I have Stage 3 COPD and recently have had to occasionally use supplemental O2. 5 mi. Descriptions. Yupelri side effects, common allergies, and other Asthma and Respiratory drugs issues at CVS, Walgreens, and other nearby pharmacies. Positive PIFR-2 results in 2023 will enhance the growth trajectory of YUPELRI. 9% YoY. 1 Mechanism of Action - Revefenacin is a long-acting muscarinic antagonist, which is often referred to as an. Copay Range. Common side effects of Yupelri include the following: Cough. The chemical name for revefenacin is. 7 out of 10 from a total of 117 ratings on Drugs. Patients should be instructed to immediately consult their healthcare provider if they develop any signs and symptoms of acute narrow-angle glaucoma, including eye pain or discomfort, blurred vision, visual halos or colored images in association with red eyes from. It is used long-term as 1 vial of YUPELRI, 1 time each day inhaled through your nebulizer to improve symptoms of COPD for better breathing. Do not use YUPELRI if you have had an allergic reaction to revefenacin, or any of the other ingredients in YUPELRI (sodium chloride, citric acid, sodium citrate) Do not use in. Slide 7 shows the Theravance Biopharma’s implied 35% share of net sales for YUPELRI during the third quarter of 2022 of $18. No other purchase is necessary. 0 out of 10 from a total of 3 ratings on Drugs. Our Story. A total of 144 drugs are known to interact with Yupelri . It’s inhaled through a mouthpiece using a nebulizer machine. Theravance ( NASDAQ: TBPH) said that it and partner Mylan have granted Teva ( NYSE: TEVA) a royalty-free, non-exclusive license to market a generic version of their drug Yupelri in the US on or. Yupelri (revefenacin) is an inhalation solution used as a maintenance treatment for chronic obstructive pulmonary disease (COPD). New or worsening eye problem called narrow-angle glaucoma. In the form of a printable coupon, rebate, savings card, free trial offers or free samples. FDA has made the determination because of the submission of applications to the Director of the U. 8% QoQ and 25. This is not a complete list of Yupelri side effects. . Step 3. You usually breathe them in with an inhaler or nebulizer. 7. Studies show that arformoterol (Brovana) can help your lungs work better and lower the risk of hospitalizations due to worsening COPD. Revefenacin, the active component of YUPELRI, is an anticholinergic. In certain limited instances, YUPELRI may be covered through a patient’s Medicare Part D pharmacy benefit. YUPELRI is taken once a day using a nebulizer. and 356 patients with tiotropium. You may be interested in these previous discussions about the Zephyr implant: – Zephyr Valve Procedure at Mayo. 3. The only recommended dosage of Yupelri is one 175 mcg vial, taken once per day. Teva has been granted a royalty-free, non-exclusive license to market generic Yupelri in the United States on or after April 23, 2039. 5 mcg/inh: Per Unit * $48. Viatris President Rajiv Malik commented, “We are pleased with the positive topline results of our Phase 3 clinical results for Yupelri in China. 7 million. Each vial contains 175 mcg of revefenacin in 3 mL of an isotonic, sterile aqueous solution containing citric acid, sodium chloride, sodium citrate, and water for injection at pH 5. This offer can be used up to a total of 12 30-day fills per calendar. The population had a mean age of 64 years (range from 41 to 88 years), with 50% males, 90% Caucasian, and had COPD with a mean post-bronchodilator forced expiratory volume in one second (FEV. com. If left untreated, this can lead to lasting eyesight loss. Top-line results from Phase III study in China demonstrate the efficacy and safety profile of YUPELRI in patients with COPD. YUPELRI gets into your lungs by just breathing calmly, deeply, and evenly for about 8 minutes, once a day. (VTRS) and Theravance Biopharma, Inc. (NASDAQ: VTRS), a global healthcare company, and Theravance Biopharma, Inc. 0 out of 10 from a total of 3 ratings on Drugs. Data from a large placebo-controlled U. hives. YUPELRI ® (revefenacin) inhalation solution, the first and only once-daily, nebulized bronchodilator approved in the US for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), achieved $47. Yupelri is specifically indicated for the maintenance treatment of patients with chronic. 9. As a positive, YUPELRI's total prescriptions and new patient starts do continue to grow. 5 , 8. (TBPH) announced positive results from the YUPELRI Phase III placebo-controlled clinical trial conducted in China assessing the efficacy and safety of YUPELRI, a once-daily nebulized long-acting muscarinic antagonist for the maintenance treatment of patients with Chronic Obstructive. The FDA approved revefenacin (Yupelri), the first once daily, nebulized bronchodilator for the treatment of chronic obstructive pulmonary disease (COPD). arformoterol. Viatris Inc. Find a pharmacy near you where you can present it (via a coupon or discount card), and. Allergic reaction: Itching or hives, swelling in your face or hands, swelling or tingling in your mouth or throat, chest tightness, trouble breathing. Both groups were well balanced for baseline characteristics with 129 treated with YUPELRI and 128 treated with. Check our savings tips for co-pay cards, assistance programs, and other ways to reduce your cost. Autoimmune Hepatitis (off-label)Venlafaxine has an average rating of 6. It works by opening the airways of the lungs. 8% QoQ and 25. Following oral administration, absolute bioavailability is <3%. 54 USE COUPON Cost With Our Coupon $48. Survey participants were aged 55 to 74 years, predominantly former smokers, and were randomly chosen from a panel of individuals with self-identified COPD. Brovana (arformoterol) is a member of the adrenergic bronchodilators drug class and is commonly used for COPD - Maintenance. (NASDAQ: TBPH) today announced positive results from. Patients should be instructed to immediately consult their healthcare provider if they develop any signs and symptoms of acute narrow-angle glaucoma, including eye pain or discomfort, blurred vision, visual halos or colored images in association with red eyes from. There are currently no generic alternatives to Tudorza Pressair. With medical big data and AI algorithms. , June 21, 2021 /PRNewswire/ -- Theravance Biopharma, Inc. 12. S. See images of Yupelri for shape, color, size and other Asthma and Respiratory drugs at CVS, Walgreens, and other nearby pharmacies. Donut Hole. The average cost for 30 Inhalation Vial For Nebulizer (s), 3ml of 175mcg/3ml each, is $1,593. The FDA’s decision was based on data from three Phase 3 trials (NCT02512510, NCT02459080, and NCT02518139), which demonstrated the efficacy and safety of Yupelri in comparison to a placebo. Yupelri coupons Other alternatives to Brovana For people seeking other alternative COPD maintenance treatments, there are a variety of different dosage forms including single medication inhalers, combination medication inhalers, and oral tablet options. For COPD, Maintenance "When I first started using this medication it worked very well. Michelle Nguyen, PharmD. Brovana Prices, Coupons and Patient Assistance Programs. Add to Medicine Chest. Save on your Yupelri prescription. While Viatris records the total net sales of YUPELRI within its financial statements, Theravance Biopharma's implied 35% share of net sales of YUPELRI for the third quarter of 2022 was $18. The NDC Packaged Code 49502-806-93 is assigned to a package of 30 pouch in 1 carton / 1 vial, single-dose in 1 pouch (49502-806-32) / 3 ml in 1 vial, single-dose of Yupelri, a human prescription drug labeled by Mylan Specialty L. 50% of reviewers reported a positive effect, while 50% reported a negative effect. Post-Donut Hole. Consumers using the ScriptSave WellRx savings program can expect average savings of 65% and, in some cases, it can be 80% or more* on brand and generic prescription drugs - that's instant savings at the register for your whole family. (NASDAQ: VTRS), a global healthcare company, and Theravance Biopharma, Inc. How often do you experience any of the following symptoms? Coughing Wheezing Shortness. 025%, 1. If paradoxical bronchospasm occurs following dosing with YUPELRI, it should be treated immediately with an inhaled, short-acting bronchodilator. Ipratropium Inhalation Solution has an average rating of 10. We have completed our review of this supplemental application. Q1 2023 YUPELRI ® (revefenacin) net sales of $47. 5 , 8. Get free coupon. The safety and efficacy of YUPELRI have been established in clinical trials when. The findings showed that Yupelri met the trial's primary efficacy endpoint by demonstrating a statistically significant rise in trough forced expiratory volume in one second (FEV 1) versus placebo. *. Please enter a search term. 10 Jan, 2022, 06:00 ET. Copay Range. Discover Viatris. Copay Range. Do not take ENTRESTO again if you have had angioedema while taking ENTRESTO. Brovana (arformoterol) is a member of the adrenergic bronchodilators drug class and is commonly used for COPD - Maintenance. 41% of reviewers reported a positive effect, while 32% reported a negative effect. 55% of reviewers reported a positive effect, while 27% reported a negative effect. Manufacturer Coupon. Breathe better with convenient, once-daily YUPELRI for 24 hours of COPD symptom relief. (NASDAQ: VTRS), a global healthcare company, and Theravance Biopharma, Inc. Daliresp (roflumilast) is a once-daily pill that lowers your risk of future chronic obstructive pulmonary disease (COPD) flare-ups. com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. See images of for shape, color, size and other drugs at CVS, Walgreens, and other nearby pharmacies. Get Yupelri for as low as $1,255. Click on a tab below…. Yupelri side effects (more detail)How ScriptSave ® WellRx Works. It works by opening the airways of the lungs, making it easier to breathe. Get discount up to 80%. Trelegy Ellipta Co-pay Coupon: Eligible commercially insured patients may pay $0 per 30/60/90-day supply (1-3 inhalers) with a maximum savings of up to $200 per month; offer valid for up to 12 uses; for additional information contact the program at 888-825-5249. 31 for 1, 60 blisters of 100mcg/62. In November 2018,. • Yupelri should be used with caution in patients with urinary retention. It offers prescription brand drugs. Just follow these 3 easy steps to start saving today! YUPELRI is covered by Medicare plans. 95 for 30, 3ml of 175mcg/3ml Inhalation Vial For Nebulizer of brand-name Yupelri with a SingleCare Yupelri coupon. S. 9% YoY. YUPELRI is a sterile, clear, colorless, aqueous solution of revefenacin. Dulera®: Advair ® HFA/Diskus ®, Breo ® Ellipta, Symbicort ® IncruseUnderstand your Yupelri prescription: side effects, dosage and how to safely use Yupelri. 27 by using the. revefenacin (Yupelri) certain inhaled corticosteroids, such as: fluticasone (Flovent) mometasone (Asmanex) ciclesonide (Alvesco) budesonide (Pulmicort)Yupelri side effects (396 reports) How the study uses the data? The study uses data from the FDA. S. YUPELRI is a sterile, clear, colorless, aqueous solution of revefenacin. Opens in a new window Opens an external website Opens an external website in a new window. Eligible, commercially insured patients may save up to $550 per 30-day prescription up to 12 times per calendar year, with a max yearly savings of $6,600. The clinical development program for YUPELRI included two 12-week, randomized, double-blind, placebo-controlled, multiple-dose, parallel-group, confirmatory trials in subjects with moderate to very severe COPD designed to evaluate the efficacy of once-daily YUPELRI’s effect on lung function (Trial 1: NCT02459080 and Trial 2: NCT02512510). Upper respiratory tract injection. Yupelri can cause serious side effects, including sudden breathing problems, new or worsened eye problems (acute narrow-angle glaucoma), or urinary retention. YUPELRI was studied in one 52-week, open-label, active-control (tiotropium 18 mcg once daily) trial. • YUPELRI is a prescription medicine used to treat chronic obstructive pulmonary disease (COPD), a long-term (chronic) lung disease that includes chronic bronchitis, emphysema, or both. 0 million, recognized by Viatris, up 8% from Q1 2022 1 Q1 2023 YUPELRI retail new patient starts and total prescriptions up 61% and 29%. Insulin Value Cash Savings Card: Offer good for up to 12 calendar months. YUPELRI is a sterile, clear, colorless, aqueous solution of revefenacin. Use this medication only with the nebulizer. Theravance Biopharma, Mylan Reach Settlement Over Inhalation Drug Yupelri. Yupelri Coupon. YUPELRI can cause serious side effects, including: Sudden shortness of breath that may be life-threatening. Theravance Biopharma to Report Third Quarter 2023 Financial Results on November. Revefenacin, the active component of YUPELRI, is an anticholinergic. 0 out of 10 from a total of 3 ratings on Drugs. While Viatris records the total net sales of YUPELRI within its financial statements, Theravance Biopharma's implied 35% share of net sales of YUPELRI for the second quarter of 2022 was $17. This website stores data such as cookies to enable essential site functionality, as well as marketing, personalization. Quantity: 6 gram(s) Dosage: 160 mcg-4. Expand current row for information about Anoro Ellipta. Arnuity® Ellipta®, Flovent® HFA/Diskus ®, Pulmicort /Flexhaler Bevespi ®®Aerosphere ®. 3. Just follow these 3 easy steps to start saving today! The YUPELRI unit-dose vial should only be removed from the foil pouch and opened IMMEDIATELY BEFORE USE. The chemical name for revefenacin is. Incruse Ellipta (umeclidinium) is used for COPD, including chronic bronchitis and emphysema. The demographic and baseline characteristics of the long-term safety trial were similar to those of the placebo-controlled 12-week studies described, with the exception that concurrent LABA or LABA/ICS therapy was used in 50% of patients. Because this reaction was reported voluntarily from a population of uncertain size, it is notYUPELRI ® (revefenacin) inhalation solution Savings Card Terms and Conditions. 2. 12/31/2023. You may report side effects to FDA at 1-800-FDA-1088. Do not use it to treat a sudden COPD flare-up. g. Sildenafil 20mg, 30 tablets. cold symptoms such as runny nose, sneezing, cough, sore throat. directions for medication usage, common dosages, and how to take drugs. Theravance Biopharma, Inc. 3. Skip to main content. Revefenacin, marketed as YUPELRI ® in the U. 50% of reviewers reported a positive effect, while 50% reported a negative effect. GAAP Net Cash Provided by Operating Activities of $971 million; and Free Cash Flow of $923 million for the Quarter; Expects Full-Year Total Revenues, Adjusted EBITDA and Free Cash Flow to be at. The out-of-pocket cost of YUPELRI varies depending on your insurance coverage. The YUPELRI unit-dose vial should only be removed from the foil. YUPELRI ® launch metrics Majority of YUPELRI ® volume flows through durable medical equipment channel (approximately 3 - month lag in data capture); remaining volume flows thro ugh hospitals, retail and long - term care pharmacies. With this Savings Card, you may pay as little as $0 for each monthly fill of YUPELRI, while this program remains in effect. Its generic name is revefenacin. 11/07/2023. Prices start at $628. 0 million Q1 2023 sales, increasing 8% year-over-year (Q1 2023 vs Q1 2022) 1 and increased its share of the long. Commercially insured patients may be eligible to save on their out-of-pocket costs with the YUPELRI Savings Card†. REVEFENACIN (rev eh FEN uh sin) treats chronic obstructive pulmonary disease (COPD). We believe in healthcare as it should be - empowering people worldwide to live healthier through every stage of life. This Savings Card may be used to reduce the amount of your out-of-pocket costs for YUPELRI up to a maximum of $550 per 30-day prescription while. Last reviewed on May 22, 2021. This Savings Card may be used to reduce the amount of your out-of-pocket costs for YUPELRI up to a maximum of $550 per 30-day prescription while. 7. With this Savings Card, you may pay as little as $0 for each monthly fill of YUPELRI, while this program remains in effect. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. Step 3. Medically. 7 out of 10 from a total of 117 ratings on Drugs.